Health News Releases

March 12, 17:15

Pharmaceutical Industry Issues Call for Collective Action to Address the Rising Global Burden of Chronic Disease

Ahead of a major UN milestone (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.who.int%2Fteams%2Fnoncommunicable-diseases%2Fon-the-road-to-2025%23Shaping%2520a%2520transformative

March 12, 11:05

Rigaku Wins Diana Nyyssonen Memorial Best Paper Award with Method for Inspecting and Measuring Defects in 3D Flash Memory

Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”) has won the Diana Nyyssonen Memorial Best Paper Award (herei

March 11, 16:40

Kenvue Announces Three New Appointments to Board of Directors

Kenvue Inc. (NYSE: KVUE), the world’s largest pure-play consumer health company by revenue, today announced the appointment of two new independent directors, Sarah Hofstetter, President of Profitero,

March 07, 13:30

BeiGene Announces Fourth Quarter and Full Year 2024 Financial Results and Business Updates

BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=54216036&newsitemid=20250227911272&lan=en-US&anchor=BeiGene&index=1&md5=e2cdff0a0d83750ab7730987260

March 07, 11:45

Novotech Releases Hepatitis B Global Clinical Trial Landscape Report 2025

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released its

March 06, 17:30

InterSystems Unveils IntelliCare: A Next-Generation, AI-Powered Electronic Health Record

InterSystems (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.intersystems.com&esheet=54216543&newsitemid=20250304321284&lan=en-US&anchor=InterSystems&index=1&md5=2a1879be82b01b2

March 06, 15:45

Galderma Delivers 2024 Record Net Sales of 4.410 Billion USD, up 9.3% Year-on-Year at Constant Currency[1], and Record Core EBITDA of 1.031 Billion USD, While Preparing to Accelerate Its Growth Trajectory Into 2025 and Beyond

Galderma Group AG (SIX:GALD), the pure-play dermatology category leader, today announced its financial results for the full year 2024, delivering strong results for another consecutive year while maki

March 06, 11:30

Parse Biosciences Advances Plans to Release Single Cell Chromatin Accessibility Products

Parse Biosciences, the leader in accessible and scalable single cell sequencing, today affirmed their plans to proceed with development and future release of their Evercode™ single cell chromatin prod

March 06, 10:10

Aster Guardians Global Nursing Award 2025 Worth $250,000 Extends Nomination Deadline to 9th March

Aster Guardians Global Nursing Award 2025 - an initiative by the leading integrated healthcare provider, Aster DM Healthcare, has extended the deadline for submission of nominations to 9th March, 2025

March 04, 10:49

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX (https://www.protagonist-inc.com/)) and Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced positive top

March 03, 13:20

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

Baszucki Group today announced a new pilot study on a ketogenic diet in bipolar disorder. “For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the stu

March 03, 12:00

Astria Therapeutics Initiates ALPHA-ORBIT Phase 3 Pivotal Trial of Navenibart in Hereditary Angioedema

Astria Therapeutics, Inc. (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fastriatx.com%2F&esheet=54215940&newsitemid=20250227320197&lan=en-US&anchor=Astria+Therapeutics%2C+Inc.&inde

March 03, 10:40

SINOVAC Announces New Board Pursuant to Privy Council Judgment and Order

Sinovac Biotech Ltd. (NASDAQ:SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that SINOVAC has received on February 8, 2025 a formal court

February 28, 16:30

Cynosure Lutronic and Amico Aesthetics Join Forces by Signing a Strategic Distribution Agreement for the Middle East

Cynosure Lutronic, a global leader in the energy-based devices market, has entered into a multi- country distribution agreement with Amico Aesthetics, a leader in providing world-class medical devices

February 28, 11:25

The Estée Lauder Companies Partners with Serpin Pharma, Inc to Develop Breakthrough Skin Care Ingredients to Advance Longevity

The Estée Lauder Companies Inc. (NYSE: EL) (ELC) today announced a collaboration with biotechnology company, Serpin Pharma, that aims to explore how their anti-inflammatory research can be applied in

February 27, 14:00

Triastek D23 (Budesonide Ileum Targeted Tablets) Receives Positive Clinical Results

Triastek announces that its 3D printed drug product D23 (Budesonide Ileum Targeted Tablets for the treatment of IgAN) has achieved positive results in recent clinical study. D23 is budesonide delayed-

February 26, 16:48

BROADMEDI and KHCA Sign Strategic MOU to Enhance Medical Tourism Services

BROADMEDI, a leading medical tourism platform of CREINNOS, has signed a strategic Memorandum of Understanding (MOU) with the Korea Hospital Coordinator Association (KHCA) to enhance service quality in

February 24, 16:43

KEYRESEARCH Launches ‘Aco-Alpha’ Nutr Supplement for Kids and Sells Out on First Day

KEYRESEARCH, a prominent name in health, announced the successful launch of its new product, ‘Aco-Alpha,’ on the 24th. It has been sold out immediately thanks to overwhelming demand. This sellout high

February 23, 13:20

ICC Arbitral Tribunal Rules in Favor of AOP Health in Arbitration Proceedings Pertaining to BESREMi® (Ropeginterferon alfa-2b)

Today, a tribunal under the auspices of the International Chamber of Commerce (ICC) served a partial final award in a dispute between PharmaEssentia Corp. (“PharmaEssentia”) and AOP Orphan Pharmaceuti

February 23, 11:50

Erectile Dysfunction: The PelviTouch Revolution Comes From DEKA’s Italian Technology

DEKA Laser, a subsidiary of El.En. S.p.A., a company operating in the Laser and Energy-Based Devices market, listed on Borsa Italiana’s Euronext STAR Milan (“STAR”), and a global leader in medical tec

February 23, 11:15

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

CareDx, Inc. (Nasdaq: CDNA) - The Transplant Company™ - a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healt

February 21, 10:40

Ferrer is the Highest-performing Pharmaceutical Company in the World for Social and Environmental Impact According to B Corp

Spanish pharmaceutical company Ferrer has reaffirmed its status as a B Corp, an international certification awarded to companies that operate with a business model centered on positive impact and meet

February 21, 09:40

Variational AI Announces Oversubscribed $5.5 Million Financing to Launch Foundation Model for Small Molecule Drug Discovery

Variational AI, the company behind Enki™, an advanced foundation model for small molecule drug discovery, today announced the completion of its oversubscribed $US5.5 million Seed extension round. Enki

February 20, 09:17

Parse Biosciences Launches 5 Million Cell Evercode WT Penta Kit for Single Cell Sequencing

Parse Biosciences, the leader in high-throughput single cell sequencing, today announced the launch of Evercode™ WT Penta and Penta 384, the first single cell RNA sequencing kits to profile 5 million

February 19, 15:15

Italian Tennis Star Jasmine Paolini Joins Amazfit as Latest Athlete Ambassador

Amazfit, a leading global smart wearables brand owned by Zepp Health (NYSE: ZEPP), today announced the signing of Italian tennis sensation and World No. 4 Jasmine Paolini as its newest global athlete

News by Region

News by Industry